Core Viewpoint - LyondellBasell (LYB) is expected to report a significant decline in quarterly earnings and revenues, with analysts revising their estimates downward, indicating a challenging financial environment for the company. Financial Performance - The anticipated quarterly earnings per share (EPS) for LyondellBasell is $0.87, reflecting a decline of 61.2% year-over-year [1] - Analysts forecast revenues of $7.41 billion, which represents a decline of 29.9% compared to the previous year [1] - The consensus EPS estimate has been revised 3.3% lower over the last 30 days, indicating a reevaluation by analysts [1] Revenue Estimates by Segment - Revenues from Advanced Polymer Solutions are expected to be $926.05 million, down 2.3% from the year-ago quarter [4] - Revenues from Olefins and Polyolefins in the Americas are projected to reach $2.73 billion, indicating a year-over-year decline of 6.7% [4] - Revenues from Intermediates & Derivatives are estimated at $2.32 billion, reflecting a decrease of 16.9% from the previous year [4] - Revenues from Olefins and Polyolefins in Europe, Asia, and International are forecasted to be $2.60 billion, down 8.5% year-over-year [5] - Revenues from Technology are expected to be $145.00 million, indicating an 8.8% decline from the prior-year quarter [5] EBITDA Estimates - EBITDA for Olefins & Polyolefins in the Americas is projected at $323.25 million, down from $670.00 million in the same quarter last year [6] - EBITDA for Olefins & Polyolefins in Europe, Asia, and International is expected to be $45.75 million, compared to $70.00 million a year ago [6] - EBITDA for Advanced Polymer Solutions is estimated at $31.88 million, down from $40.00 million in the previous year [7] - EBITDA for Technology is projected to be $67.58 million, compared to $84.00 million last year [7] - EBITDA for Intermediates & Derivatives is expected to reach $253.36 million, down from $794.00 million in the same quarter last year [8] Stock Performance - LyondellBasell shares have increased by 2.1% over the past month, while the Zacks S&P 500 composite has risen by 3.4% [8] - The company holds a Zacks Rank of 5 (Strong Sell), indicating expectations of underperformance relative to the overall market in the near term [8]

Group 1 - Analysts expect SBA Communications (SBAC) to report quarterly earnings of $3.12 per share, reflecting a year-over-year decline of 5.2% [1] - Revenue is anticipated to be $670.06 million, which represents a 1.5% increase from the same quarter last year [1] - There have been no revisions in the consensus EPS estimate over the last 30 days, indicating stability in analysts' forecasts [1] Group 2 - Analysts forecast 'Revenues- Site Development' to reach $44.19 million, indicating a year-over-year increase of 29.9% [3] - 'Revenues- International Site Leasing' is expected to be $157.61 million, showing a year-over-year decline of 3.5% [4] - 'Revenues- Domestic Site Leasing' is projected to be $462.11 million, reflecting a slight year-over-year decrease of 0.2% [4] - The average prediction for 'Revenues- Site Leasing' is $619.71 million, indicating a year-over-year decline of 1.1% [4] Group 3 - Analysts expect 'Sites owned - International' to total 22,303, compared to 22,283 a year ago [5] - 'Sites owned - Domestic' is projected to reach 17,455, slightly down from 17,461 year-over-year [5] - The consensus for 'Segment operating profit- Site Leasing (Domestic + International)' is $505.28 million, down from $512.33 million in the previous year [5] Group 4 - The estimated 'Segment operating profit- Site Development' is $8.78 million, an increase from $6.88 million reported in the same quarter last year [6] - 'Depreciation, accretion and amortization' is expected to be $69.30 million according to analysts [6] - SBA Communications shares have decreased by 4.1% over the past month, contrasting with a 3.4% increase in the Zacks S&P 500 composite [6]

Core Viewpoint - The upcoming earnings report for XPO is expected to show a decline in both earnings per share and revenue compared to the previous year, indicating a downward trend in financial performance [1]. Financial Performance - Analysts predict quarterly earnings of $0.99 per share, reflecting an 11.6% decline year-over-year [1]. - Revenue is forecasted to be $2.04 billion, which represents a 1.8% decrease compared to the same quarter last year [1]. - The consensus EPS estimate has been revised downward by 3.9% over the past 30 days, indicating a reappraisal by analysts [1]. Segment Performance - Revenue for the European Transportation Segment is expected to reach $793.91 million, down 1.7% from the prior-year quarter [4]. - The North American Less-Than-Truckload Segment is projected to generate $1.24 billion in revenue, reflecting a year-over-year decline of 2.3% [4]. - The Adjusted Operating Ratio is anticipated to be 82.9%, slightly improved from 83.2% reported in the same quarter last year [4]. Key Metrics - The number of working days is expected to remain at 64, consistent with the previous year [5]. - Shipments per day are forecasted to be 50,737, down from 53,519 in the year-ago period [5]. - Gross revenue per hundredweight (excluding fuel surcharges) is estimated at $25.16, up from $23.56 a year ago [5]. - Gross revenue per hundredweight (including fuel surcharges) is projected to be $29.18, compared to $28.04 in the same quarter last year [6]. - The average weight per shipment is expected to be 1,343.1 pounds, down from 1,358.0 pounds in the previous year [6]. - Net revenue per shipment is estimated at $388.45, compared to $370.98 a year ago [7]. - Pounds per day are projected to be 68.15 million, down from 72.66 million in the same quarter last year [7]. EBITDA Estimates - Adjusted EBITDA for the European Transportation Segment is expected to be $36.99 million, down from $49.00 million in the same quarter last year [8]. - Adjusted EBITDA for the North American Less-Than-Truckload Segment is projected to be $300.53 million, slightly up from $297.00 million a year ago [8]. Stock Performance - XPO shares have increased by 3.9% over the past month, outperforming the Zacks S&P 500 composite's increase of 3.4% [9]. - XPO currently holds a Zacks Rank 4 (Sell), indicating expectations of underperformance relative to the overall market in the near term [9].

Core Insights - Idexx Laboratories (IDXX) is expected to report quarterly earnings of $3.31 per share, a 35.7% increase year-over-year, with revenues projected at $1.07 billion, reflecting a 6.3% year-over-year growth [1] Earnings Projections - The consensus EPS estimate for the quarter has been revised upward by 0.7% over the past 30 days, indicating a collective reassessment by analysts [2] - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3] Revenue Estimates - Revenue from the Companion Animal Group (CAG) is forecasted to reach $978.21 million, a 6.1% increase from the previous year [5] - Revenue from Other segments is expected to be $4.41 million, up 3.9% year-over-year [5] - Livestock and poultry diagnostics (LPD) revenue is projected at $31.51 million, reflecting a 4% increase [5] - Water revenue is anticipated to be $50.79 million, indicating an 8.7% year-over-year growth [6] - Revenue from the Companion Animal Group in the United States is estimated at $663.10 million, a 5.5% increase [6] - International revenue from the Companion Animal Group is expected to be $312.95 million, up 6.6% year-over-year [7] - LPD International revenue is projected at $25.76 million, reflecting a 2.2% increase [7] - Water International revenue is expected to reach $24.16 million, indicating an 8.5% year-over-year growth [7] Gross Profit Estimates - Gross Profit for the Companion Animal Group (CAG) is expected to be 62.6%, compared to 61.7% in the same quarter last year [8] - Gross Profit for Other segments is estimated at 29.6%, down from 57.8% year-over-year [8] - Gross Profit for LPD is projected at 51.7%, slightly up from 51.3% in the previous year [8] - Gross Profit for Water is expected to be 69.6%, compared to 68.6% in the same quarter last year [9] Stock Performance - Over the past month, Idexx shares have returned +5.6%, outperforming the Zacks S&P 500 composite's +3.4% change [9] - Based on its Zacks Rank 3 (Hold), IDXX is expected to perform in line with the overall market in the upcoming period [10]

Core Insights - Clorox (CLX) is expected to report quarterly earnings of $2.24 per share, a 23.1% increase year-over-year, with revenues projected at $1.93 billion, reflecting a 1.5% increase compared to the same period last year [1] Earnings Estimates - Over the past 30 days, the consensus EPS estimate has been revised downward by 3.2%, indicating a reassessment by analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock performance [3] Revenue Projections - Analysts predict 'Net Revenue- Health and Wellness' at $692.86 million, a 6.3% increase year-over-year [5] - 'Net Revenue- International' is estimated to be $249.98 million, showing a decline of 7.8% year-over-year [5] - The consensus for 'Net Revenue- Lifestyle' stands at $349.59 million, indicating a 6.6% increase from the previous year [5] - 'Net Revenue- Household' is estimated at $626.55 million, reflecting a 5% increase year-over-year [6] Income Estimates - 'Income before income taxes- Health and Wellness' is expected to reach $219.10 million, up from $202.00 million year-over-year [7] - 'Income before income taxes- International' is projected at $21.21 million, compared to $18.00 million last year [7] - 'Income before income taxes- Lifestyle' is likely to be $71.73 million, an increase from $61.00 million in the same quarter last year [8] - 'Income before income taxes- Household' is estimated at $102.89 million, compared to $98.00 million year-over-year [8] Stock Performance - Clorox shares have increased by 2.8% over the past month, while the Zacks S&P 500 composite has risen by 3.4% [8] - Clorox holds a Zacks Rank 5 (Strong Sell), indicating expected underperformance relative to the overall market in the near term [8]

Wall Street analysts forecast that ArcelorMittal (MT) will report quarterly earnings of $1.31 per share in its upcoming release, pointing to a year-over-year increase of 107.9%. It is anticipated that revenues will amount to $15.74 billion, exhibiting a decrease of 3.1% compared to the year-ago quarter. The consensus EPS estimate for the quarter has been revised 5.4% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initia ...

Core Insights - Wall Street analysts forecast TransMedics (TMDX) will report quarterly earnings of $0.48 per share, reflecting a year-over-year increase of 37.1% [1] - Anticipated revenues for the quarter are projected to be $147.37 million, representing a 28.9% increase compared to the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the past 30 days, indicating analysts' reassessment of their projections [1] Revenue Estimates - Analysts predict 'Net revenue by OCS product- OCS Lung net revenue' will reach $4.50 million, indicating a year-over-year decrease of 4.2% [4] - The estimate for 'Net revenue by OCS product- OCS Liver net revenue' is $108.56 million, showing a significant increase of 40.9% from the prior-year quarter [4] - 'Net revenue by OCS product- OCS Heart net revenue' is expected to be $32.38 million, reflecting a 3% increase from the previous year [4] Geographic Revenue Insights - 'Geographic Revenues- United States' is expected to be $142.05 million, indicating a year-over-year increase of 31% [5] - 'Geographic Revenues- All other countries' is projected to be $4.47 million, showing a decrease of 5.2% from the prior-year quarter [5] Stock Performance - TransMedics shares have decreased by 17.8% over the past month, contrasting with the Zacks S&P 500 composite's increase of 4.9% [5] - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to closely follow overall market performance in the near term [5]

Core Viewpoint - Analysts forecast that Xylem (XYL) will report quarterly earnings of $1.14 per share, reflecting a year-over-year increase of 4.6%, with anticipated revenues of $2.21 billion, showing a 2.1% increase compared to the previous year [1] Earnings Estimates - Over the last 30 days, there has been a 0.2% upward revision in the consensus EPS estimate for the quarter, indicating a collective reassessment by covering analysts [2] - Revisions to earnings estimates are crucial indicators for predicting potential investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3] Revenue Projections - Analysts predict 'Revenue- Measurement & Control Solutions' will reach $509.46 million, a change of +5.7% year-over-year [5] - The consensus estimate for 'Revenue- Applied Water' stands at $459.40 million, suggesting a change of +0.8% year-over-year [5] - 'Revenue- Water Infrastructure' is projected to reach $639.53 million, indicating a +1.4% change from the year-ago quarter [5] - The average prediction for 'Revenue- Water Solutions and Services' is $605.08 million, reflecting a +0.9% change from the prior-year quarter [6] Adjusted Operating Income Estimates - Analysts expect 'Adjusted Operating Income- Water Infrastructure' to be $124.64 million, up from $101.00 million reported in the same quarter last year [6] - The estimated 'Adjusted Operating Income- Applied Water' is $80.10 million, compared to $73.00 million in the same quarter of the previous year [7] - 'Adjusted Operating Income- Water Solutions and Services' is projected at $98.21 million, slightly down from $99.00 million reported in the same quarter last year [7] - The consensus for 'Adjusted Operating Income- Measurement & Control Solutions' is $84.05 million, compared to $96.00 million from the previous year [8] Stock Performance - Over the past month, shares of Xylem have returned +3.4%, while the Zacks S&P 500 composite has changed by +4.9% [8] - Currently, XYL holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [8]

Core Viewpoint - DexCom (DXCM) is expected to report quarterly earnings of $0.45 per share, reflecting a 4.7% increase year-over-year, with revenues projected at $1.12 billion, indicating an 11.8% year-over-year growth [1]. Financial Estimates - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days, indicating analysts' stable outlook [1]. - Analysts forecast 'Revenue- Hardware' to reach $38.99 million, showing a year-over-year decline of 32% [4]. - 'Revenue- Sensor and other' is projected to be $1.08 billion, suggesting a year-over-year increase of 14.5% [4]. - 'Revenue- United States' is expected to be $809.70 million, reflecting a 10.6% increase from the prior-year quarter [4]. - 'Revenue- International' is likely to reach $311.29 million, indicating a year-over-year growth of 14.3% [5]. Market Performance - Over the past month, DexCom shares have returned +3.1%, compared to the Zacks S&P 500 composite's +4.9% change [5]. - DexCom holds a Zacks Rank 2 (Buy), suggesting it is likely to outperform the overall market in the upcoming period [5].

Core Viewpoint - Illinois Tool Works (ITW) is expected to report quarterly earnings of $2.56 per share, a 0.8% increase year-over-year, with revenues forecasted at $4.01 billion, reflecting a 0.4% decrease from the previous year [1] Earnings Projections - The consensus EPS estimate has been revised 0.6% higher in the last 30 days, indicating a collective reevaluation by analysts [2] - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3] Revenue Estimates - Analysts estimate 'Operating Revenues- Test & Measurement and Electronics' at $672.53 million, a decrease of 0.8% year-over-year [5] - 'Operating Revenues- Construction Products' is projected to reach $492.87 million, down 2.2% from the prior year [5] - 'Operating Revenues- Food Equipment' is expected to be $666.24 million, reflecting a slight decrease of 0.1% [6] - 'Operating Revenues- Specialty Products' is estimated at $445.56 million, indicating a 0.8% decline [6] - 'Operating Revenues- Automotive OEM' is forecasted at $790.60 million, a decrease of 3% [6] - 'Operating Revenues- Welding' is projected to be $467.18 million, showing a year-over-year increase of 0.3% [7] - 'Operating Revenues- Polymers & Fluids' is expected to reach $447.66 million, down 1.4% from the previous year [7] Operating Income Estimates - 'Operating Income- Automotive OEM' is expected to be $157.86 million, slightly up from $157.00 million in the same quarter last year [8] - 'Operating Income- Food Equipment' is projected at $182.17 million, compared to $180.00 million a year ago [8] - 'Operating Income- Test & Measurement and Electronics' is estimated at $163.47 million, up from $159.00 million year-over-year [9] - 'Operating Income- Specialty Products' is forecasted at $141.02 million, down from $144.00 million in the previous year [9] Stock Performance - Over the past month, ITW shares have returned +6.1%, outperforming the Zacks S&P 500 composite's +4.6% change [9]